List of Otsuka's Acquisitions
Here's the year on year acquisition history of Otsuka:
Year | # Acquisitions |
|---|---|
2018 | 2 |
2017 | 2 |
2014 | 1 |
2013 | 1 |
2008 | 1 |
1998 | 1 |
1989 | 1 |
Recent acquisitions by Otsuka
Otsuka's most recent acquisition - Visterra is a Developer of monoclonal antibodies against infectious diseases, founded in 2007 and located in Cambridge. Otsuka acquired it in July 2018 for a price of $*****.
Here is the list of all acquisitions by Otsuka sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Jul 11, 2018 | ggpj | wqfq | 29 | 918 | |
Jul 10, 2018 | eavx | rwrd | 43 | 901 | |
Jul 27, 2017 | ifry | wqxq | 22 | 401 | |
Mar 02, 2017 | xgrs | wzth | 12 | 230 | |
Dec 02, 2014 | pplh | sdaw | 51 | 986 |
View the full list of acquisitions
Sign Up for FreeNews related to Otsuka's acquisitions
Media has covered Otsuka for a total of 23 events in the last 1 year, 5 of them have been about acquisition activity.
•
Otsuka Acquires Transcend Therapeutics for $700M UpfrontEndpoints•Mar 27, 2026•Transcend Therapeutics, Otsuka
•
PANTHERx Rare selected by Otsuka to dispense VOYXACT for IgA Nephropathy treatmentPR Newswire•Dec 18, 2025•PANTHERx Rare, Otsuka
•
4DMT and Otsuka Enter Exclusive Licensing Agreement for 4D-150 in Asia-PacificGlobeNewswire•Oct 31, 2025•4D Molecular Therapeutics, Otsuka
•
Otsuka Pharmaceutical acquires Cantargia’s CAN10 program in a deal worth over USD 600 millionStock Screener•Jul 17, 2025•Otsuka, Cantargia
•
Otsuka to acquire Cantargia’s CAN10 for autoimmune diseases
Pharmaceutical Technology•Jul 15, 2025•Otsuka, Cantargia